Provided by Tiger Fintech (Singapore) Pte. Ltd.

Context Therapeutics Inc.

0.6602
+0.00891.37%
Post-market: 0.67960.0194+2.94%19:23 EDT
Volume:87.37K
Turnover:56.09K
Market Cap:59.22M
PE:-1.87
High:0.6602
Open:0.6520
Low:0.6305
Close:0.6513
Loading ...

Bet on These 5 Top-Ranked Stocks With Rising P/E

Zacks
·
21 Apr

Context Therapeutics Is Maintained at Buy by D. Boral Capital

Dow Jones
·
09 Apr

BRIEF-Context Therapeutics Doses First Patient In Phase 1 Clinical Trial Of Ct-95

Reuters
·
09 Apr

Context Therapeutics Begins Phase 1 Trial for CT-95

TIPRANKS
·
09 Apr

Context Therapeutics Doses First Patient in Phase 1 Clinical Trial of Ct-95

THOMSON REUTERS
·
09 Apr

Zacks.com featured highlights include Context Therapeutics, Blue Bird, Dycom Industries and Leidos

Zacks
·
04 Apr

Context Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
01 Apr

Companies Like Context Therapeutics (NASDAQ:CNTX) Are In A Position To Invest In Growth

Simply Wall St.
·
22 Mar

Context Therapeutics Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
21 Mar

BRIEF-Context Therapeutics Reports Full Year 2024 Operating And Financial Results

Reuters
·
21 Mar

Context Therapeutics FY 2024 GAAP EPS $(0.46) Beats $(0.58) Estimate

Benzinga
·
21 Mar

Context Therapeutics Reports Full Year 2024 Operating and Financial Results

THOMSON REUTERS
·
21 Mar

Context Therapeutics: Co Expects Its Cash and Cash Equivalents Will Continue to Fund Operations Into 2027

THOMSON REUTERS
·
21 Mar

Press Release: Context Therapeutics Reports Full Year 2024 Operating and Financial Results

Dow Jones
·
21 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
17 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
14 Mar

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
25 Feb

Sector Update: Health Care Stocks Rise Premarket Wednesday

MT Newswires Live
·
15 Jan

BRIEF-Context Therapeutics Says First Patient Dosed In The Phase 1 Clinical Trial Of CTIM-76

Reuters
·
15 Jan

Context Therapeutics Doses First Patient in Phase 1 Cancer Treatment Trial

MT Newswires Live
·
15 Jan